Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05209451 · ClinicalTrials.gov registry record · NA
Increasing Digital Equity and Access Among Rural Patients (IDEA) Study
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT05209451: Completed NA study, sponsored by Mayo Clinic.
NCT05209451 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05209451, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this research is to learn more about how access to digital resources impacts healthcare and smoking cessation in rural areas of Minnesota, Iowa, and Wisconsin. Aim 1: Conduct a pragmatic randomized clinical trial and use mixed methods to assess the impact of providing access to technology and/or coaching support on participation in and response to a digital, evidence-based behavioral health program for smoking cessation. Aim 2: Assess the feasibility and patient experience of providing electronic remuneration and a loaner device with data plan coverage to access the Internet for remote clinical trials participation.
Primary Outcome
Composite measure of assessment completion and use of online cessation program
Interventions
- BEHAVIORAL Digital, evidence-based behavioral health program for smoking cessation
- OTHER Bluetooth enabled iPad
- BEHAVIORAL Coaching Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-02-11 |
| Est. Completion | 2023-02-17 |
| Phase | NA |
What the finished NCT05209451 record still lists
NCT05209451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Digital, evidence-based behavioral health program for smoking cessation is the first listed.
NCT05209451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05209451 about?
NCT05209451 is a clinical study titled "Increasing Digital Equity and Access Among Rural Patients (IDEA) Study". The purpose of this research is to learn more about how access to digital resources impacts healthcare and smoking cessation in rural areas of Minnesota, Iowa, and Wisconsin. Aim 1: Conduct a pragmatic randomized clinical trial and use mixed methods to assess the impact of providing access to techn...
What is the current status of trial NCT05209451?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2022-02-11. Estimated completion is 2023-02-17.
What interventions are being tested in trial NCT05209451?
The interventions under investigation include: Digital, evidence-based behavioral health program for smoking cessation (BEHAVIORAL), Bluetooth enabled iPad (OTHER), Coaching Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT05209451?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05209451's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI